Literature DB >> 28879829

Five-year surveillance of human tuberculosis caused by Mycobacterium bovis in Bologna, Italy: an underestimated problem.

G Lombardi1, I Botti1, M L Pacciarini2, M B Boniotti2, G Roncarati1, P Dal Monte1.   

Abstract

Human tuberculosis (TB) caused by Mycobacterium bovis surveillance is affected by a lack of data. The aims of the present study were: (i) to estimate the proportion of human TB caused by M. bovis over a period of 5 years in Bologna, Northern Italy, which, like most Western European countries, has been declared bovine TB-free; (ii) to compare the genetic profiles of M. bovis strains identified in humans with those circulating in cattle in the last 15 years in Italy. Among 511 TB patients, the proportion of human TB caused by M. bovis was 1·76%, significantly associated to extra-pulmonary localization (P = 0·004) and to being elderly (P < 0·001) and Italy-born (P = 0·036). The molecular epidemiology analysis by spoligotyping and Multilocus Variable Tandem Repeat Analysis confirmed that most M. bovis strains from Italy-born patients matched those circulating in cattle herds in Italy between 2001 and 2016. Two cases of Mycobacterium bovis BCG infection were also characterized. In conclusion, the rate of human TB caused by M. bovis was not negligible, highlighting the relevance of molecular typing in evaluating the effectiveness of programmes designed to eradicate TB in cattle in Italy.

Entities:  

Keywords:  zzm321990 Mycobacterium bovis (M. bovis); Bovine tuberculosis (bTB); Multilocus Variable Tandem Repeat Analysis (MLVA); human tuberculosis (TB); spoligotyping

Mesh:

Year:  2017        PMID: 28879829      PMCID: PMC9152750          DOI: 10.1017/S0950268817001996

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  11 in total

1.  Association of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease.

Authors:  N Lari; L Rindi; R Cristofani; N Rastogi; E Tortoli; C Garzelli
Journal:  Clin Microbiol Infect       Date:  2009-03-19       Impact factor: 8.067

2.  The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2016.

Authors: 
Journal:  EFSA J       Date:  2017-12-12

3.  Molecular and epidemiological population-based integrative analysis of human and animal Mycobacterium bovis infections in a low-prevalence setting.

Authors:  Juan José Palacios; Yurena Navarro; Beatriz Romero; Ana Penedo; Ángela Menéndez González; M Dolores Pérez Hernández; Ana Fernández-Verdugo; Francisca Copano; Aurora Torreblanca; Emilio Bouza; Lucas Domínguez; Lucía de Juan; Darío García-de-Viedma
Journal:  Vet Microbiol       Date:  2016-08-26       Impact factor: 3.293

4.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Genetic diversity of human isolates of Mycobacterium bovis assessed by spoligotyping and Variable Number Tandem Repeat genotyping.

Authors:  Nicoletta Lari; Nicola Bimbi; Laura Rindi; Enrico Tortoli; Carlo Garzelli
Journal:  Infect Genet Evol       Date:  2010-09-22       Impact factor: 3.342

6.  Molecular typing of Mycobacterium bovis strains isolated in Italy from 2000 to 2006 and evaluation of variable-number tandem repeats for geographically optimized genotyping.

Authors:  M Beatrice Boniotti; Maria Goria; Daniela Loda; Annalisa Garrone; Alessandro Benedetto; Alessandra Mondo; Ernesto Tisato; Mariagrazia Zanoni; Simona Zoppi; Alessandro Dondo; Silvia Tagliabue; Stefano Bonora; Giorgio Zanardi; M Lodovica Pacciarini
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

Review 7.  Current knowledge and pending challenges in zoonosis caused by Mycobacterium bovis: a review.

Authors:  Laura Pérez-Lago; Yurena Navarro; Darío García-de-Viedma
Journal:  Res Vet Sci       Date:  2013-12-01       Impact factor: 2.534

8.  Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance.

Authors:  Miriam Bobadilla-del Valle; Pedro Torres-González; Miguel Enrique Cervera-Hernández; Areli Martínez-Gamboa; Brenda Crabtree-Ramirez; Bárbara Chávez-Mazari; Narciso Ortiz-Conchi; Luis Rodríguez-Cruz; Axel Cervantes-Sánchez; Tomasa Gudiño-Enríquez; Carmen Cinta-Severo; José Sifuentes-Osornio; Alfredo Ponce de León
Journal:  PLoS Negl Trop Dis       Date:  2015-09-30

9.  Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis.

Authors:  Pedro Torres-Gonzalez; Orbelin Soberanis-Ramos; Areli Martinez-Gamboa; Barbara Chavez-Mazari; Ma Teresa Barrios-Herrera; Martha Torres-Rojas; Luis Pablo Cruz-Hervert; Lourdes Garcia-Garcia; Mahavir Singh; Adrian Gonzalez-Aguirre; Alfredo Ponce de Leon-Garduño; José Sifuentes-Osornio; Miriam Bobadilla-Del-Valle
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

10.  Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.

Authors:  Jennifer A Davidson; Miranda G Loutet; Catherine O'Connor; Cathriona Kearns; Robert M M Smith; Maeve K Lalor; H Lucy Thomas; Ibrahim Abubakar; Dominik Zenner
Journal:  Emerg Infect Dis       Date:  2017-03       Impact factor: 6.883

View more
  2 in total

1.  One Health and surveillance of zoonotic tuberculosis in selected low-income, middle-income and high-income countries: A systematic review.

Authors:  Rodrigo de Macedo Couto; Giulia Osório Santana; Otavio T Ranzani; Eliseu Alves Waldman
Journal:  PLoS Negl Trop Dis       Date:  2022-06-06

Review 2.  Occupational exposure and challenges in tackling M. bovis at human-animal interface: a narrative review.

Authors:  K Renuga Devi; L J Lee; Lee Tze Yan; Amin-Nordin Syafinaz; I Rosnah; V K Chin
Journal:  Int Arch Occup Environ Health       Date:  2021-03-16       Impact factor: 3.015

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.